This is a working overview of MOD GRF 1-29, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-08-19 and is reviewed periodically as new material appears.
Identity and purity are established with reversed phase high performance liquid chromatography coupled to mass spectrometry. The chromatographic step separates the target peptide from truncated sequences and deletion products, while the mass measurement confirms the expected molecular weight to within a fraction of a dalton. Because the two common variants differ by the presence of the linker, mass alone can distinguish them in the unconjugated state. Amino acid analysis and peptide mapping are used when sequence level confirmation is required.
Lyophilized material is generally stable for extended periods when held at minus twenty degrees Celsius or below and protected from moisture and light. In solution the peptide is more labile; bond hydrolysis, aggregation and oxidation of susceptible residues all proceed faster at ambient temperature. Repeated freeze and thaw cycles should be avoided because they promote clumping and loss of soluble material. The conjugated variant adds a further consideration, since the maleimide group can hydrolyze in aqueous buffer and lose its ability to react with albumin.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Two forms circulate in research settings and are frequently confused. One carries the drug affinity complex and is often written as CJC-1295 with DAC; the other lacks that group and is usually called modified GRF(1-29). The two share the same core sequence but differ sharply in how long they persist in blood. Products labelled only as CJC-1295 normally refer to the version carrying the complex. Documentation that omits the distinction leaves the intended molecule ambiguous.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off white powder | Typical lyophilized form |
| Water solubility | Soluble | May need a small organic co-solvent |
| Purity assessment | Chromatographic peak area | Most certificates report a percentage figure |
| Storage temperature | Minus 20 C or lower | Dry, dark, sealed container |
| Identity check | Electrospray mass spectrometry | Compared against theoretical mass |
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
The two variants differ dramatically in how long they persist in circulation. The form lacking the albumin-binding group has a plasma half-life measured in tens of minutes, comparable to the natural hormone fragment. The version carrying the drug affinity complex binds albumin and shows a half-life of roughly six to eight days in human studies. That figure comes from small trials that tracked hormone levels over extended periods. The physiological consequences of sustained versus pulsatile stimulation are still debated and the literature does not settle the point.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
The dividing feature between the two forms is a maleimide-based drug affinity complex, abbreviated DAC. In the DAC-bearing version, a linker attaches the peptide to serum albumin after administration, and that association slows removal from plasma. The version lacking DAC appears in catalogs as MOD GRF(1-29) or tetrasubstituted GRF(1-29). Because informal writing treats both as one item, comparisons drawn from such sources routinely blend measurements taken from two molecules with substantially different behavior.
Four amino acid substitutions separate the modified backbone from the parent GRF(1-29) sequence. These changes reduce recognition by dipeptidyl peptidase IV and related proteases, extending the interval before degradation. Development work in this area sought longer-acting GHRH analogs for endocrine investigation. Published descriptions treat the substitution set as a defining property of the core sequence, while the albumin-binding linker is described separately as an optional addition to that same backbone.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
The Inner London Education Authority (ILEA) was the local education authority for the City of London and the 12 Inner London boroughs from 1965 until its abolition in 1990. From 1965 to 1986 it was an ad hoc committee of the Greater London Council; on 1 April 1986 it was reconstituted as a directly elected body corporate.
In 1907, American tea merchant Thomas Sullivan began distributing samples of his tea in small bags of silk with a drawstring. Consumers noticed they could simply leave the tea in the bag and reuse it with fresh tea. However, the potential of this distribution and packaging method would not be fully realised until later. During World War II, tea was rationed in the United Kingdom. In 1953, after rationing in the UK ended, Yorkshire-based tea manufacturer Tetley launched the tea bag in the UK, and it was an immediate success. The "pyramid tea bag" (or sachet), introduced by Lipton and PG Tips/Scottish Blend in 1996, attempts to address one of the connoisseurs' arguments against paper tea bags by way of its three-dimensional tetrahedron shape, which allows more room for tea leaves to expand while steeping. However, some types of pyramid tea bags have been criticised as being environmentally unfriendly, since their synthetic material is not as biodegradable as loose tea leaves and paper tea bags.
== Sources == Vitamin K1 is primarily from plants, especially leafy green vegetables. Small amounts are provided by animal-sourced foods. Vitamin K2 is primarily from animal-sourced foods, with poultry and eggs much better sources than beef, pork or fish. One exception to the latter is nattō, which is made from bacteria-fermented soybeans. It is a rich food source of vitamin K2 variant MK-7, made by the bacteria.
Sources: en.wikipedia.org
In June 2023, The U.S. Food and Drug Administration (FDA) authorized for marketing Eroxon, an over-the-counter non-medicated hydro-alcoholic gel indicated for treatment of erectile dysfunction. In the clinical trial, erection was achieved by most men within ten minutes after applying the gel. The gel is manufactured by Futura Medical, a British medical company. The gel is regulated as a medical device and not as a drug, because its mode of action is a physical one and it doesn't have an active pharmaceutical ingredient. Eroxon is the first topical ED treatment sold over the counter in the United States. The gel had been on sale in Europe under a CE mark since 2023, and it reached American shops in October 2024. As of 2026, the gel is sold in the United States, United Kingdom, Europe, and several countries in Latin America and the Middle East.
== Function == The protein encoded by this gene contains a leucine-rich repeat and a death domain. This protein has been shown to interact with other death domain proteins, such as Fas (TNFRSF6)-associated via death domain (FADD) and MAP-kinase activating death domain-containing protein (MADD), and thus may function as an adaptor protein in cell death-related signaling processes. The expression of the mouse counterpart of this gene has been found to be positively regulated by the tumor suppressor p53 and to induce cell apoptosis in response to DNA damage, which suggests a role for this gene as an effector of p53-dependent apoptosis. Three alternatively spliced transcript variants encoding distinct isoforms have been reported. Besides its pro-apoptotic function it may also be involved in DNA repair as part of a protein complex formed together with the catalytic subunit of DNA-PK (DNA-PKcs) and caspase 2. Signaling pathways involving PIDD-C have been associated with the activation of NF-κB and the promotion of cell survival. Following DNA damage, PIDD-C relocates to the nucleus, where it forms a complex with RIP1 and the NF-kappa-B inhibitor kinase subunit gamma (NEMO, or IKBKG), collectively referred to as the 'NEMO-PIDDosome.' PIDD1 is also essential for translesion DNA synthesis (TLS), which enables DNA elongation across lesions in response to UV exposure.
Peak areas are calculated from HPLC traces of dry samples of the substance to be tested in 1 ml of acetonitrile. The standard used to calibrate the calculation is 1 gram of capsaicin. Scoville heat units are found by multiplying the ppmH value by a factor of 15. By this definition of ppmH, spicy compounds other than the two most important capsaicinoids are ignored, despite the ability of HPLC to measure these other compounds at the same time.
=== Summum === In 1975, an esoteric organization by the name of Summum introduced "Modern Mummification", a service that utilizes modern techniques along with aspects of ancient methods of mummification. The first person to formally undergo Summum's process of modern mummification was the founder of Summum, Summum Bonum Amen Ra, who died in January 2008. Summum is currently considered to be the only "commercial mummification business" in the world.
Sources: en.wikipedia.org
Hong Kong generates most of its electricity locally. The vast majority of this energy comes from fossil fuels, with 46% from coal and 47% from petroleum. The rest is from other imports, including nuclear energy generated in mainland China. Renewable sources account for a negligible amount of energy generated for the territory. Small-scale wind-power sources have been developed, and a small number of private homes and public buildings have installed solar panels. With few natural lakes and rivers, high population density, inaccessible groundwater sources, and extremely seasonal rainfall, the territory lacks a reliable freshwater supply. The Dong River in Guangdong supplies 70% of the city's water, with the remaining demand met by harvesting rainwater locally. Toilets in most built-up areas of the territory flush with seawater, which reduces freshwater use. Broadband Internet access is widely available, with 99.3% of households connected. Connections over fibre-optic infrastructure are increasingly prevalent, contributing to the high regional average connection speed of 21.9 Mbit/s (the world's fourth-fastest). Mobile-phone use is ubiquitous; there are almost 22 million mobile-phone accounts registered in Hong Kong, which is almost triple the territory's population.
== Further reading == Als, Hilton (Summer 2012). "Wallace Shawn, The Art of Theater No. 17". The Paris Review. Summer 2012 (201). Higgins, J. (2012). "The End of Room-Space: Domesticity and the Absent Audience in Wallace Shawn's the Fever". Journal of Dramatic Theory and Criticism. 26 (2): 57–74. doi:10.1353/dtc.2012.0017. S2CID 191948394. King, W. D. (1997). Writing Wrongs: The Work of Wallace Shawn. Philadelphia: Temple University Press. ISBN 1-56639-517-8. Shawn, Wallace, "The End of a Village", The New York Review of Books, vol. LXXI, no 15 (3 October 2024), pp. 16–17.
=== May === May 1 Iran war: President Donald Trump notifies lawmakers in Congress that the Iran war has been "terminated" ahead of a 60-day deadline under the War Powers Resolution which military operations must halt unless lawmakers authorize military force. 2026 May Day protests: May Day protests are held across the U.S., including an economic blackout as part of 3,500 "May Day Strong" events across the country. Additionally, demonstrations are held outside institutions such as the New York Stock Exchange. British singer Zayn Malik cancels all U.S. concert events for his upcoming Konnakol tour after being hospitalized for an unknown illness. May 2 2026 Kentucky Derby: In horse racing, American racehorse Golden Tempo wins the 152nd Kentucky Derby after entering the race with a 24–1 odds, making Cherie DeVaux the first female trainer to win the derby. Spirit Airlines announces it has gone out of business after 34 years. May 3 – Iran war: President Trump announces Operation Project Freedom in an effort to secure commercial traffic across the Strait of Hormuz. May 4 Iran war: The U.S. Central Command confirms the launch of Operation Project Freedom in an effort to secure commercial traffic across the Strait of Hormuz. Danish shipping company Maersk reports that the Alliance Fairfax, a US-flagged vehicle carrier operated by subsidiary Farrell Lines, has successfully crossed the Strait of Hormuz accompanied by U.S. military assets as part of Project Freedom. Iran is reported to have fired missiles and drones at military and commercial ships.
Most modern nuclear weapons utilize 238U as a "tamper" material (see nuclear weapon design). A tamper which surrounds a fissile core works to reflect neutrons and to add inertia to the compression of the 239Pu charge. As such, it increases the efficiency of the weapon and reduces the critical mass required. In the case of a thermonuclear weapon, 238U can be used to encase the fusion fuel, the high flux of very energetic neutrons from the resulting fusion reaction causes 238U nuclei to split and adds more energy to the "yield" of the weapon. Such weapons are referred to as fission-fusion-fission weapons after the order in which each reaction takes place. An example of such a weapon is Castle Bravo. The larger portion of the total explosive yield in this design comes from the final fission stage fueled by 238U, producing enormous amounts of radioactive fission products. For example, an estimated 77% of the 10.4-megaton yield of the Ivy Mike thermonuclear test in 1952 came from fast fission of the depleted uranium tamper. Because depleted (or natural) uranium has no critical mass, it can be added to thermonuclear bombs in almost unlimited quantity. The Soviet Union's test of the Tsar Bomba in 1961 produced "only" 50 megatons of explosive power, over 90% of which came from fusion because the 238U final stage had been replaced with lead. Had 238U been used instead, the yield of the Tsar Bomba could have been well above 100 megatons, and it would have produced nuclear fallout equivalent to one third of the global total that had been produced up to that time.
=== Insulin glargine === Insulin glargine is a long-acting modified form of medical insulin used in the management of type 1 and type 2 diabetes. It is administered through subcutaneous injection. Its effects typically begin within an hour of injection. Common side effects include (hypoglycemia, issues at the injection site, itchiness, and weight gain. NPH insulin is generally preferred over insulin glargine during pregnancy. After injection, microcrystals gradually release insulin over a period of approximately 24 hours. This insulin works by facilitating the absorption of glucose by body tissues and reducing glucose production by the liver. Insulin glargine was patented, although the patent expired in most countries in 2014. It was approved for medical use in the United States in 2000. It is listed on the World Health Organization's List of Essential Medicines. In 2022, it ranked as the 28th most commonly prescribed medication in the United States, with more than 18 million prescriptions. In July 2021, the US Food and Drug Administration (FDA) approved an interchangeable biosimilar insulin product, Semglee (insulin glargine-yfgn), for the treatment of diabetes. Unbranded versions of insulin glargine and insulin glargine-yfgn are sold by Sanofi and Viatris.
Sources: en.wikipedia.org
The mass difference from the linker is large enough for routine detection by mass spectrometry. The unconjugated form gives a single sharp signal at its expected weight. Material that has already reacted with albumin shows a much higher mass and a broadened chromatographic peak.
Yes. Degradation proceeds faster once the powder is dissolved, especially at room temperature or after multiple freeze and thaw cycles. Working solutions are often aliquoted to avoid repeated handling. Lyophilized powder held cold and dry retains its properties far longer.
Truncated sequences, oxidized residues and aggregated forms can all elute near the main peak. Reversed phase chromatography resolves many of these species, so the number of peaks is a useful indicator of synthesis quality. A single peak does not by itself prove correct sequence, which is why mass confirmation is paired with it.
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.